Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-13-003030
Filing Date
2013-02-19
Accepted
2013-02-19 19:06:31
Documents
1
Period of Report
2013-02-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 8150
  Complete submission text file 0001179110-13-003030.txt   9450
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 937-6100
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
CHASE WILLIAM J (Reporting) CIK: 0001563572 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35565 | Film No.: 13624875